Pregnancy outcomes in autoinflammatory disease
To address this, a French multi-centre prospective pregnancy observational cohort was set up, to…
View Resource
ILD Begins (8.29.2025)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com. This week news…
View Resource
Anakinra's Effects on COVID-19 Outcomes
Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…
View Resource
EULAR 2023 Notes from Milan (6.09.2023)
Dr. Jack Cush reviews highlight abstracts and sessions – covering lupus, RA, gout, Still’s…
View Resource
Sniffles & Arthritis (3.1.2024)
Dr. Jack Cush reviews the news and journal reports from the past week on…
View Resource
ACR 2024 – Day 2 Report
Plenary sessions began the day, followed by thousands on the abstract floor. Here are…
View Resource
EULAR 2025 – Day 4 Report
Saturday was the final day of EULAR, and included several lectures, but mostly late…
View Resource
Emapalumab Approved for MAS in Still’s
On June 27th, 2025, the FDA approved emapalumab for macrophage activation syndrome (MAS) in…
View Resource
Tocilizumab Risk of Diverticulitis and GI Perforation
A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…
View Resource
JAK Inhibitors in Difficult Still’s Disease
A small retrospective study suggests that patients with difficult to treat adult-onset Still’s disease…
View Resource